Endothelin Adrenocortical Secretagogue Effect Is Mediated by the B Receptor in Rats
- 1 May 1996
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 27 (5) , 1153-1159
- https://doi.org/10.1161/01.hyp.27.5.1153
Abstract
We investigated the gene expression and localization of endothelin-1 (ET-1) receptor subtypes ET A and ET B in the rat adrenal cortex as well as their involvement in the corticosteroid secretagogue effect of ET-1 in vitro. Reverse transcription–polymerase chain reaction with primers specific for ET A and ET B cDNAs demonstrated the expression of both receptor genes in homogenates of adrenocortical tissue. However, in isolated zona glomerulosa and zona fasciculata cells, only ET B mRNA was detected. Autoradiographic examination of the selective displacement of 125 I–ET-1 binding by BQ-123 and BQ-788 (specific ligands for ET A and ET B , respectively) indicated that zona glomerulosa possesses both ET A and ET B , whereas zona fasciculata is exclusively provided with ET B . ET-1 enhanced in a concentration-dependent manner aldosterone and corticosterone secretions of dispersed zona glomerulosa and zona fasciculata cells, respectively. The ET B antagonist BQ-788 markedly reduced the secretory response of zona glomerulosa cells and completely suppressed that of zona fasciculata cells, whereas the ET A antagonist BQ-123 was ineffective. These findings indicate that in the rat, the adrenocortical secretagogue action of ET-1 is mediated by the ET B receptor subtype and that the ET A receptor is not directly involved in such an effect.Keywords
This publication has 38 references indexed in Scilit:
- The current endothelin receptor classification: time for reconsideration?Trends in Pharmacological Sciences, 1994
- Gene expression, localization, and characterization of endothelin A and B receptors in the human adrenal cortex.Journal of Clinical Investigation, 1994
- Endothelin-1 stimulation of aldosterone and zona glomerulosa ouabain-sensitive sodium/potassium-ATPaseThe Journal of Steroid Biochemistry and Molecular Biology, 1994
- Retraction concerning an endothelin B receptor‐selective antagonist: Urade, Y., Fujitani, Y., Oda, K., Watakabe, T., Umemura, L., Takai, M., Okada, T., Sakata, K. and Karaki, H. (1992) FEBS Lett. 311, 12‐16FEBS Letters, 1994
- Molecular signalling in gametesJournal of Endocrinology, 1994
- Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptorLife Sciences, 1992
- An endothelin B receptor‐selective antagonist: IRL 1038, [Cys11‐Cys15]‐endothelin‐1(11–21)FEBS Letters, 1992
- Sarafotoxin S6c: An agonist which distinguishes between endothelin receptor subtypesBiochemical and Biophysical Research Communications, 1991
- Endothelin receptor subtypes and stimulation of aldosterone secretion.Hypertension, 1990
- Endothelin binding to cultured calf adrenal zona glomerulosa cells and stimulation of aldosterone secretion.Journal of Clinical Investigation, 1989